Skip to main content
Premium Trial:

Request an Annual Quote

That Paper You've Been Meaning to Write

As many universities have cancelled in-person classes and they and businesses have encouraged people to work from home to help slow the spread of SARS-CoV-2, the virus behind the ongoing COVID-19 pandemic, Bitesize Bio writes there are a number of tasks researchers could take on if they are unable to work in their labs.

One idea, it says, is to go through data that's been collected and write it up into a paper. Even if there isn't quite enough there for it to be submitted, Bitesize Bio notes that this exercise would underline what needs to be done once the lab is back open. Similarly, it says this time of isolation is an opportunity to conduct a literature review and organize references.

Another idea it has is to practice and polish up any presentations and that this could even be done in front of a virtual audience — which it notes would also keep people in touch with one another. 

Additionally, Bitesize Bio adds that people could use this time to learn a new skill, such as coding, but also to take the time to take care of themselves.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.